Company Analysis United Health Products, Inc.
1. Summary
Advantages
- Price (0.14 $) is less than fair price (0.1869 $)
- The company's current efficiency (ROE=153.03%) is higher than the sector average (ROE=13.16%)
Disadvantages
- Dividends (0%) are below the sector average (1.73%).
- The stock's return over the last year (-38.14%) is lower than the sector average (-4.97%).
- Current debt level 275.72% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
18 november 16:52 Aflac CEO says company adapted to health care in a 'post-COVID world'
2.3. Market efficiency
| United Health Products, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -3.1% | -6% | -5.7% |
| 90 days | 68.7% | -1.3% | -7.3% |
| 1 year | -38.1% | -5% | 8.8% |
UEEC vs Sector: United Health Products, Inc. has significantly underperformed the "Healthcare" sector by -33.17% over the past year.
UEEC vs Market: United Health Products, Inc. has significantly underperformed the market by -46.98% over the past year.
Slightly volatile price: UEEC is more volatile than the rest of the market on "OTC" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: UEEC with weekly volatility of -0.7335% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.14 $) is lower than the fair price (0.1869 $).
Price significantly below the fair price: The current price (0.14 $) is 33.5% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (31.91).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (51.38).
4.3. P/BV
P/BV vs Sector: The company's P/BV (-29.29) is lower than that of the sector as a whole (3.26).
P/BV vs Market: The company's P/BV (-29.29) is lower than that of the market as a whole (-9.02).
4.4. P/S
P/S vs Sector: The company's P/S indicator (1324.35) is higher than that of the sector as a whole (3.22).
P/S vs Market: The company's P/S indicator (1324.35) is higher than that of the market as a whole (4.71).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-21.02) is lower than that of the sector as a whole (10.21).
EV/Ebitda vs Market: The company's EV/Ebitda (-21.02) is lower than that of the market as a whole (27.8).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -12.05% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-12.05%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-44.01%).
5.4. ROE
ROE vs Sector: The company's ROE (153.03%) is higher than that of the sector as a whole (13.16%).
ROE vs Market: The company's ROE (153.03%) is higher than that of the market as a whole (5.09%).
5.5. ROA
ROA vs Sector: The company's ROA (-921.6%) is lower than that of the sector as a whole (6.08%).
ROA vs Market: The company's ROA (-921.6%) is lower than that of the market as a whole (16.55%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.03%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.73%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
